NCT02360878View on ClinicalTrials.gov

The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones

CompletedOBSERVATIONAL
Enrollment

25

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

July 31, 2017

Conditions
Type 2 DiabetesObesity
Interventions
DEVICE

EndoBarrier Gastrointestinal Liner

Implantation with the EndoBarrier

Trial Locations (1)

2900

Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup

All Listed Sponsors
collaborator

University of Copenhagen

OTHER

lead

Filip Krag Knop

OTHER

NCT02360878 - The Endocrine Impact of the Duodenal-jejunal Bypass Sleeve on Type 2 Diabetes - Potential Role of the Incretin Hormones | Biotech Hunter | Biotech Hunter